Press Releases

Active Biotech AB Interim report January - March 2014
April 24, 2014 08:30 (CEST)
Active Biotech - Notice of Annual General Meeting of Shareholders
April 14, 2014 08:35 (CEST)
Active Biotech - Notice of Annual General Meeting of Shareholders
April 14, 2014 08:30 (CEST)
Annual Report 2013 Active Biotech AB (publ)
April 7, 2014 10:10 (CEST)
Annual Report 2013 Active Biotech AB (publ)
April 7, 2014 10:00 (CEST)
Change in the clinical development program for laquinimod
February 19, 2014 14:03 (CET)
Change in the clinical development program for laquinimod
February 19, 2014 14:00 (CET)
Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:37 (CET)
Active Biotech AB Year-end report January - December 2013
February 13, 2014 08:30 (CET)
Teva and Active Biotech Remain Committed to the Development of NERVENTRA® (laquinimod) for Multiple Sclerosis Following the Negative Opinion from the EMA's CHMP
January 24, 2014 13:13 (CET)